Differential responses of cord and adult blood-derived dendritic cells to dying cells

被引:23
|
作者
Wong, OH
Huang, FP
Chiang, AKS [1 ]
机构
[1] Univ Hong Kong, Queen Mary Hosp, Dept Paediat & Adolescent Med, Pokfulam, Hong Kong, Peoples R China
[2] Univ Hong Kong, Queen Mary Hosp, Dept Pathol, Pokfulam, Hong Kong, Peoples R China
关键词
apoptosis; cord blood; cytokines; dendritic cell; necrosis; lymphoblastoid cells;
D O I
10.1111/j.1365-2567.2005.02191.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Normal turnover of body tissues yields apoptotic cells while infections cause tissue injuries and cell necrosis. The interaction of these dying cells with dendritic cells (DCs) may provide immunological instructions leading to either immune tolerance or activation. We hypothesize that neonatal and adult DCs differ in their responses to dying cells, thereby contributing to the observed differences in immune responses between neonates and adults. We compare the outcome of interaction of cord and adult blood-derived DCs with dying Epstein-Barr-virus-transformed lymphoblastoid cells (LCLs) and the responsiveness to lipopolysaccharide. While cord DCs were able to phagocytose both apoptotic and necrotic LCLs, the subsequent responses differed significantly from those of adult DCs. Interaction of adult DCs with necrotic but not early apoptotic LCLs resulted in high expression of DC costimulatory molecules (CD80/CD86) and activation markers (CD83), production of both proinflammatory and anti-inflammatory cytokines (tumour necrosis factor-alpha, interleukin-10), and strong T-cell-stimulating activities. In contrast, in response to either necrotic or apoptotic LCLs, cord DCs had minimal up-regulation of those DC functional markers, little cytokine production and poor stimulation on T-cell proliferation. In response to lipopolysaccharide, however, both adult and cord DCs produced comparable levels of tumour necrosis factor-alpha and interleukin-10, but only adult DCs produced interleukin-12(p70). Taken together, these results suggest that neonatal DCs generally favour immune tolerance with minimal activation and cytokine production, except in extremely dangerous situations, such as bacterial sepsis, when neonatal DCs may produce certain types of cytokines and stimulate T-cell proliferation.
引用
收藏
页码:13 / 20
页数:8
相关论文
共 50 条
  • [31] Nanofiber technology in the ex vivo expansion of cord blood-derived hematopoietic stem cells
    Ferreira, Monica Sofia Ventura
    Mousavi, Seyed Hadi
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2018, 14 (05) : 1707 - 1718
  • [32] Immunoregulatory effect of human β-defensin 1 on neonatal cord blood monocyte-derived dendritic cells and T cells
    Wu, Jing
    Gong, Ruo-Lan
    Hu, Qing-Feng
    Chen, Xu-Ting
    Zhao, Wei
    Chen, Tong-Xin
    MOLECULAR IMMUNOLOGY, 2019, 109 : 99 - 107
  • [33] Alveolar Epithelial Cell Therapy with Human Cord Blood-Derived Hematopoietic Progenitor Cells
    De Paepe, Monique E.
    Mao, Quanfu
    Ghanta, Sailaja
    Hovanesian, Virginia
    Padbury, James F.
    AMERICAN JOURNAL OF PATHOLOGY, 2011, 178 (03) : 1329 - 1339
  • [34] Combined growth factors enhanced angiogenic potential of cord blood-derived mononuclear cells transplanted to ischemic limbs
    Kim, Moo Hyun
    Zhang, Hong-Zhe
    Kim, Sung-Whan
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2011, 51 (05) : 702 - 712
  • [35] Cord Blood-Derived Multipotent Stem Cells Ameliorate in Vitro/in Vivo Alloreactive Responses, and This Effect Is Associated with Exosomal Microvesicles in Vitro
    Descalzi-Montoya, Dante B.
    Yang, Zheng
    Fanning, Stacey
    Hu, Wei
    Lomauro, Katherine
    Zhao, Yong
    Korngold, Robert
    TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (04): : 396.e1 - 396.e14
  • [36] Cryopreserved Human Umbilical Cord Blood-derived Angiogenic Cells Therapy for Ischemic hindlimb in Mice
    Kim, Sung-Whan
    Sohn, Young-Doug
    Byun, Ki Hyun
    TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2009, 6 (4-11) : 805 - 810
  • [37] Humanized system to propagate cord blood-derived multipotent mesenchymal stromal cells for clinical application
    Reinisch, Andreas
    Bartmann, Christina
    Rohde, Eva
    Schallmoser, Katharina
    Bjelic-Radisic, Vesna
    Lanzer, Gerhard
    Linkesch, Werner
    Strunk, Dirk
    REGENERATIVE MEDICINE, 2007, 2 (04) : 371 - 382
  • [38] Endothelial progenitor cell differentiation using cryopreserved, umbilical cord blood-derived mononuclear cells
    Jang, Jun-ho
    Kim, Sun-kyung
    Choi, Jeong-eun
    Kim, Young-jin
    Lee, Hyun-woo
    Kang, Seok-yun
    Park, Joon-seong
    Choi, Jin-hyuk
    Lim, Ho-yeong
    Kim, Hugh C.
    ACTA PHARMACOLOGICA SINICA, 2007, 28 (03) : 367 - 374
  • [39] Integration of functional bacterial artificial chromosomes into human cord blood-derived multipotent stem cells
    F Zaibak
    J Kozlovski
    J Vadolas
    J P Sarsero
    R Williamson
    S E Howden
    Gene Therapy, 2009, 16 : 404 - 414
  • [40] Gene expression accompanied by differentiation of cord blood-derived CD34+cells to eosinophils
    Hashida, R
    Ogawa, K
    Miyagawa, M
    Sugita, Y
    Matsumoto, K
    Akasawa, A
    Saito, H
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2001, 125 : 2 - 6